TG Therapeutics
TGTX
#2862
Rank
A$8.17 B
Marketcap
A$51.21
Share price
-0.81%
Change (1 day)
-18.87%
Change (1 year)

Earnings for TG Therapeutics (TGTX)

Earnings in 2025 (TTM): A$0.20 Billion

According to TG Therapeutics's latest financial reports the company's current earnings are A$0.61 Billion. , an increase over its 2024 earnings that were of A$69.57 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for TG Therapeutics from 1996 to 2025

Annual earnings

Year Earnings Change
2025 A$0.18 B169.57%
2024 A$69.57 M93.76%
2023 A$35.9 M-113.65%
2022 -A$0.27 Billion-45.06%
2021 -A$0.48 Billion25.42%
2020 -A$0.39 Billion62.93%
2019 -A$0.24 Billion-3.34%
2018 -A$0.25 Billion46.05%
2017 -A$0.17 Billion48.38%
2016 -A$0.12 Billion29.09%
2015 -A$86.68 Million12.99%
2014 -A$76.71 Million180.92%
2013 -A$27.31 Million
2009 -A$2.48 Million-59.85%
2008 -A$6.18 Million
2006 -A$13.99 Million-48.34%
2005 -A$27.07 Million215.12%
2004 -A$8.6 Million29.1%
2003 -A$6.66 Million159.59%
2002 -A$2.57 Million
2000 -A$4.41 Million12.38%
1999 -A$3.92 Million7.69%
1998 -A$3.64 Million-49.02%
1997 -A$7.14 Million82.14%
1996 -A$3.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Alkermes
ALKS
A$0.42 B 126.46%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Dr. Reddy's Laboratories
RDY
A$1.22 B 551.19%๐Ÿ‡ฎ๐Ÿ‡ณ India